These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35656669)
21. Molecular cytogenetics in acute myeloid leukemia in adult patients: practical implications. Mrózek K Pol Arch Intern Med; 2022 Aug; 132(7-8):. PubMed ID: 35848612 [TBL] [Abstract][Full Text] [Related]
22. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies. Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587 [TBL] [Abstract][Full Text] [Related]
23. Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice. Pathak R; Koturbash I; Hauer-Jensen M J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117817 [TBL] [Abstract][Full Text] [Related]
24. Comparative genomic hybridization based strategy for the analysis of different chromosome imbalances detected in conventional cytogenetic diagnostics. Tönnies H; Stumm M; Wegner RD; Chudoba I; Kalscheuer V; Neitzel H Cytogenet Cell Genet; 2001; 93(3-4):188-94. PubMed ID: 11528111 [TBL] [Abstract][Full Text] [Related]
25. Methodologies in cancer cytogenetics and molecular cytogenetics. Wang N Am J Med Genet; 2002 Oct; 115(3):118-24. PubMed ID: 12407691 [TBL] [Abstract][Full Text] [Related]
26. Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Schröck E; Padilla-Nash H Semin Hematol; 2000 Oct; 37(4):334-47. PubMed ID: 11071356 [TBL] [Abstract][Full Text] [Related]
27. Cancer Cytogenetics: An Introduction. Wan TS Methods Mol Biol; 2017; 1541():1-10. PubMed ID: 27910009 [TBL] [Abstract][Full Text] [Related]
28. The history of human cytogenetics in India-A review. Dutta UR Gene; 2016 Sep; 589(2):112-7. PubMed ID: 26850130 [TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Sawyer JR Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186 [TBL] [Abstract][Full Text] [Related]
30. Comparative genomic hybridization in clinical cytogenetics. Bryndorf T; Kirchhoff M; Rose H; Maahr J; Gerdes T; Karhu R; Kallioniemi A; Christensen B; Lundsteen C; Philip J Am J Hum Genet; 1995 Nov; 57(5):1211-20. PubMed ID: 7485173 [TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetics of lymphoma: where do we stand in 2010? Kluin P; Schuuring E Histopathology; 2011 Jan; 58(1):128-44. PubMed ID: 21261688 [TBL] [Abstract][Full Text] [Related]
32. Updates in cytogenetics and molecular markers in MDS. Tiu RV; Visconte V; Traina F; Schwandt A; Maciejewski JP Curr Hematol Malig Rep; 2011 Jun; 6(2):126-35. PubMed ID: 21340513 [TBL] [Abstract][Full Text] [Related]
33. The new cytogenetics: blurring the boundaries with molecular biology. Speicher MR; Carter NP Nat Rev Genet; 2005 Oct; 6(10):782-92. PubMed ID: 16145555 [TBL] [Abstract][Full Text] [Related]
34. Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances. Dave BJ; Sanger WG Semin Pediatr Neurol; 2007 Mar; 14(1):2-6. PubMed ID: 17331878 [TBL] [Abstract][Full Text] [Related]
35. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Van Limbergen H; Poppe B; Michaux L; Herens C; Brown J; Noens L; Berneman Z; De Bock R; De Paepe A; Speleman F Genes Chromosomes Cancer; 2002 Jan; 33(1):60-72. PubMed ID: 11746988 [TBL] [Abstract][Full Text] [Related]
36. Advances in molecular cytogenetics for the evaluation of mental retardation. Xu J; Chen Z Am J Med Genet C Semin Med Genet; 2003 Feb; 117C(1):15-24. PubMed ID: 12561054 [TBL] [Abstract][Full Text] [Related]
37. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-. Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625 [TBL] [Abstract][Full Text] [Related]
38. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833 [TBL] [Abstract][Full Text] [Related]
39. Cytogenetic Resources and Information. De Braekeleer E; Huret JL; Mossafa H; Dessen P Methods Mol Biol; 2017; 1541():311-331. PubMed ID: 27910033 [TBL] [Abstract][Full Text] [Related]